Compare Gilead Sciences, Inc. (GILD) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Peloton Interactive Inc — how do they compare? Gilead Sciences, Inc. trades at $147.01 (market cap $182.40B), while Peloton Interactive Inc trades at $4.92 (market cap $2.16B). The key difference: Gilead Sciences, Inc. is far larger — about 84.4× Peloton Interactive Inc's market cap, and Gilead Sciences, Inc. pays a 2.23% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and Peloton Interactive Inc for 37 Days on average.
| GILD | PTON | |
|---|---|---|
Market Cap | $182.40B | $2.16B |
Volume | 4,469,821 | 11,369,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $155.80 | $7.86 |
52-Week Low | $116.74 | $3.71 |
Typical Hold Time | 111 Days | 37 Days |
Enterprise Value | $205.46B | $2.66B |
Dividend Yield | 2.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $146.85, up 1.82% with bullish technical signals and strong analyst support. Recent earnings beat expectations in three consecutive quarters, though Q2 showed a significant loss. The company maintains robust operating cash flow of $10.02B (2025) and expanded HIV prevention access through a major PAHO partnership. Valuation metrics show a P/E of 17.84 and P/S of 6.02, with revenue growth from $29.44B (2025) to projected $30.5B (2026).
Outlook remains positive with 65% analyst buy ratings and $151.57 consensus target, though risks include negative net income margin (-10.64%) and high debt levels. The stock offers dividend income ($0.82 upcoming) and pipeline catalysts in oncology/HIV, but investors should monitor earnings volatility and competitive pressures in biopharma.
Peloton (PTON) trades at $4.85, down 0.41% on the day, as the stock remains under technical pressure with bearish moving average signals. Fundamentally, the company achieved its first full-year net profit in fiscal 2026 with a 2.58% margin, while revenue declined to $2.4B. Recent product launches include a new foldable Tread Flex treadmill and AI-powered coaching features, signaling continued turnaround efforts under CEO Peter Stern's leadership.
The outlook remains challenged despite profitability improvements, with analyst consensus pointing to significant upside (target $8.00) but technical weakness and declining subscriber counts creating headwinds. Key risks include execution of the turnaround strategy, competitive pressure in connected fitness, and high debt levels, though cost-cutting measures show early success.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
